10/8/2015. MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH. None

Size: px
Start display at page:

Download "10/8/2015. MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH. None"

Transcription

1 MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH None 1

2 Objectives Why the need for change in the guidelines? What is the potential impact of these guidelines? Where do we go from here? Kannel et al. Ann Intern Med

3 Kannel et al. AJC

4 Kannel et al. American Journal of Cardiology The relationship between Cholesterol and CHD is Linear MrFIT JAMA

5 Distributions of cholesterol levels and age-adjusted CHD deaths. Psaty B M Circulation 2010;121:

6 The Benefit of Statin Therapy is Independent of Baseline LDL Cholesterol CVD, DM or HTN Source: HPS Collaborative Group. Lancet 2002;360:7-22 Can you go to low? Hsia et al. JACC

7 Statin Good - More Statin Better Statin Therapy in Hypertensive Individuals Reduced CHD Events Source: Sever PS et al. Lancet. 2003;361:

8 Statin Therapy in Individuals with Diabetes Reduced CHD Events LDL <160mg/dl Atorvastatin 10mg Stopped early CARDS Trial New Cholesterol Guidelines Overall Theme Statins should be used to reduce ASCVD risk in individuals most likely to benefit Absolute risk is better predictor of benefit than cholesterol Statin therapy should be allocated based on absolute risk 8

9 Objectives Why the need for change in the guidelines? What is the potential impact of these guidelines? Where do we go from here? The 4 Statin Groups Known Clinical CVD Type II Diabetes LDL-C >190mg/dl Individuals with a >7.5% 10-year CVD Risk 9

10 Implications US Adults (40-75) in millions Statin-Eligibility in the U.S. Total Population ATP III ACC/AHA Pencina et al, NEJM 2014 Statin Eligibility in ARIC ASCVD Diabetes LDL > 190 CVD > 7.5% All 4 groups Miedema et al JAMA-IM

11 Objectives Why the need for change in the guidelines? What is the potential impact of these guidelines? Where do we go from here? Coronary Artery Calcium Score Mammogram of the heart Quantifies the amount of plaque in the coronary arteries ~.8 millisievert of Radiation Cost $100 11

12 Plaque Burden Strongly Correlates with CHD Risk Detrano et al. NEJM 2007 Mortality by CAC and age Tota-Maharaj European Heart Journal

13 Mortality by CAC and Risk Factors CAC Distribution by age MESA 13

14 CAC and CVD Events-Intermediate FRS Yeboah et al. JAMA. 2012; 308(8): CAC and CVD Events ACC/AHA Risk Calculator Sensitivity ASCVD ASCVD + CAC ASCVD + hscrp ASCVD + FH ASCVD + ABI , P= , P= , P= , P= Specificity Yeboah et al. AHA

15 CAC distribution across Statin Eligibility Groups 100% 90% 80% CAC distribution 70% 60% 50% 40% 30% % 41 10% 0% Recommend Statins Consider Statins Statins not recommended CAC = 0 CAC CAC > 100 Nasir et al. JACC 2015 CAC distribution Across Spectrum of 10 Year Risk Score Among those >7.5% Risk Score 100% CAC = 0 CAC CAC > 100 CAC distribution 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% % % % 20% N=431 N=608 N=342 N=441 15

16 CHD Event Rate Per 1000 Person Among Non Diabetics with LDL mg/dl Across Spectrum of CAC Burden & Increasing 10 Year ASCVD Risk >7.5% Categories CAC=0 CAC CAC> % % % 20% N=431 N=608 N=342 N=441 Dotted line represent reference line for 10 year ASCVD risk estimate of 7.5% ASCVD Event Rate Per 1000 Person Among Non Diabetics with LDL mg/dl Across Spectrum of CAC Burden & Increasing 10 Year ASCVD Risk >7.5% Categories CAC=0 CAC CAC> % % % 20% N=431 N=608 N=342 N=441 Dotted line represent reference line for 10 year ASCVD risk estimate of 7.5% 16

17 MESA An Evidenced-based Heart Healthy Diet Michael Miedema, MD MPH October 7th,

18 Objectives The obesity epidemic why are we gaining weight? Dietary fat intake very evil, not so evil.. healthy? An evidence based heart healthy diet what does the science really support? Levels of Evidence Anecdotal Basic Science/surrogate outcomes Observational Studies Randomized Controlled Trials 36 18

19 Anecdotal Evidence 37 Levels of Evidence Anecdotal Basic Science/surrogate outcomes Observational Studies Randomized Controlled Trials 38 19

20 The obesity epidemic Objectives Dietary fat intake An evidence based heart healthy diet

21 21

22 22

23 Prevalence of Self-Reported Obesity Among U.S. Adults % <20% 20% <25% 25% <30% 30% <35% 35% What Changed? Physical Inactivity? Processed foods? Dietary Pattern? Effect of tobacco and alcohol use? Poor Sleep? More Food? 23

24 We are eating more Trends in food consumption: 24

25 The importance of the food environment Plate size Moving from a 12 inch to a 10 inch dinner plate leads people to serve and eat 22% less. Low fat labels lead people to eat 16 23% more total calories. The Nutritional Gatekeeper influences an estimated 72% of all of the food their family eats. Visual illusions People pour 28% more into a short wide glasses than tall ones. Bulk purchases 50% of the snack food bought in bulk (such as at a warehouse club store) is eaten within six days of purchase. 25

26 Lessons from soup Single bowl vs self refilling bowl 8.5 oz vs 14.7 oz No difference in estimated consumption No difference in satiety Take Home Point #1 Your food environment has a significant impact on what and how much you eat 52 26

27 Does obesity cause CHD? CHD mortality rates The obesity epidemic Objectives Dietary fat intake An evidence based heart healthy diet 27

28 Conventional Wisdom? Total Fat, Saturated Fat Serum Total and LDL Cholesterol Coronary Heart Disease Total Fat Intake and Heart Disease Seven Countries Study 28

29 Dietary Fats & LDL-Cholesterol =0.032* SFA Change in LDL-C (mmol/l) =-0.009* =-0.019* 0 1% 2% 3% 4% 5% percentage of calories vs. carbohydrate MUFA PUFA Based on Mensink & Katan Figure from Micha & Mozaffarian, Lipids 2010 Dietary Fats & HDL Cholesterol 0.05 SFA HDL-C, mmol/l MUFA PUFA % 2% 3% 4% 5% percentage of calories vs. carbohydrate Based on a meta-analysis of 13 RCTs. Mozaffarian & Clarke, EJCN

30 Dietary Fats & Total Cholesterol Total:HDL-C Ratio SFA MUFA PUFA 0 1% 2% 3% 4% 5% percentage of calories vs. carbohydrate Based on a meta-analysis of 13 RCTs. Mozaffarian & Clarke, EJCN 2009 Total Fat and CHD Prospective Cohorts RR I II III IV V 28.3% 32.6% 35.6% 38.7% 44.0% Quintiles of Total Fat Consumption 77,878 women in the Nurses Health Study, , Oh et al, AJE

31 Food Sources: Red Meat Unprocessed Red Meat RR = 1.00 (0.81, 1.23) Processed Meats RR = 1.42 (1.07, 1.89) Micha et al., Circulation 2010 Food Sources: Milk/Dairy Multivariable adjusted relative risk comparing the highest to the lowest intake Mozaffarian D. Nutrition and Cardiovascular Disease. Chapter 48. Braunwald's Heart Disease; A Textbook of Cardiovascular Medicine, 9th Edition

32 If saturated fat goes out, what goes in? Change in CHD Risk for Each 5% Energy SFA PUFA * SFA Carb * Total of 344,696 individuals with 5,249 CHD events. *p<0.05 Jakobsen et al, AJCN 2009 If Saturated goes out, what goes in? SFA Low Glycemic Index Carb SFA Med Glycemic Index Carb Change in CHD Risk for Each 5% Energy SFA High Glycemic Index Carb * Risk of CHD among 53,644 adults followed for 12 years. *p<0.05 Jakobsen et al, AJCN

33 Take Home Point #2 Dietary fat intake does not appear to be as harmful as we once thought And maybe healthy? The obesity epidemic Objectives Dietary fat intake An evidence based heart healthy diet 33

34 Saturated Fat and Heart Disease No Significant Effect HR = 0.97 (95% CI = 0.90, 1.06) Women s Health Initiative RCT 48,835 US women, randomized to low fat, low saturated fat diet vs. control. Howard et al, JAMA

35 In Healthy Fat = Heart Attacks and Strokes 35

36 36

37 37

38 Can I just wait until I m 50 at then eat Healthy? Fruits and Vegetables during young adulthood and future plaque build up Odds Ratio Q1 (Reference) Q2 Q3 Miedema et al. Fruits and Vegetable and CAC CARDIA. ACC

39 Chocolate and CHD Alcohol and Cardiovascular Disease Matsumoto, Miedema, et al. Alcohol and Cardiovascular Disease. Journal of Prevention and Cardiopulmonary Rehab. In Press. 39

40 What Counts as a drink? Alcohol and Risk of CHD 40

41 Pattern of Use and CHD Pooled Analysis of Studies of Cardiac Death Relative Risk of Cardiac Death Total risk reduction = 36% (95% CI= 20 to 50%; p<0.001) mg/day EPA+DHA Intake (mg/d) (~ 2 g/week) Mozaffarian & Rimm. JAMA

42 Fish Oil No benefit to supplementation 42

43 Multivitamins No benefit 43

44 A heart healthy diet Mozaffarian & Ludwig, JAMA 2010 Special Thanks Dary Mozaffarian Mike Gaziano Luc Djousse The MHIF 44

45 45

Cardiac patient quality of life. How to eat adequately?

Cardiac patient quality of life. How to eat adequately? Cardiac patient quality of life How to eat adequately? François Paillard CV Prevention Center CHU Rennes JESFC, Paris, 17/01/2013 Mrs. L. 55 yrs, Coronary artery disease, normal weight, mild hypertension

More information

Pattern of lipid biomarkers and risk of cardiovascular disease

Pattern of lipid biomarkers and risk of cardiovascular disease Pattern of lipid biomarkers and risk of cardiovascular disease Robert Clarke Clinical Trial Service Unit University of Oxford 9 January 2017 Biomarkers for dietary fats Blood lipids (LDL, HDL, triglycerides,

More information

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease

More information

Low carbohydrate diets- do they have a place?

Low carbohydrate diets- do they have a place? Low carbohydrate diets- do they have a place? Grant Schofield Professor of Public Health AUT University, Auckland NZ @grantsnz www.facebook.com/profgrant www.profgrant.com Atherogenic dyslipidemia is [primarily]

More information

Healthy Fats & Fatty Acids Current Dietary Recommendations and Popular Opinions

Healthy Fats & Fatty Acids Current Dietary Recommendations and Popular Opinions Healthy Fats & Fatty Acids Current Dietary Recommendations and Popular Opinions Presentation 1 of 2 Penny M. Kris-Etherton PhD RD FAHA FNLA FASN CLS Department of Nutritional Sciences Penn State University

More information

Lipid Management 2013 Statin Benefit Groups

Lipid Management 2013 Statin Benefit Groups Clinical Integration Steering Committee Clinical Integration Chronic Disease Management Work Group Lipid Management 2013 Statin Benefit Groups Approved by Board Chair Signature Name (Please Print) Date

More information

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary 2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth

More information

No relevant financial relationships

No relevant financial relationships MANAGEMENT OF LIPID DISORDERS Balancing Benefits and harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial relationships baron@medicine.ucsf.edu

More information

Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health

Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health Robert Clarke Clinical Trial Service Unit University of Oxford 28 th May

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials MANAGEMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR RISK IN WOMEN: Balancing Benefits and Harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial

More information

Going Coconut over Saturated Fat? Why So Much Confusion? Part 1 Interpreting Conflicting Research

Going Coconut over Saturated Fat? Why So Much Confusion? Part 1 Interpreting Conflicting Research Going Coconut over Saturated Fat? Why So Much Confusion? Part 1 Interpreting Conflicting Research Disclosures Alice H Lichtenstein Board Member/Advisory Panel Food and Nutrition Board, National Academies

More information

New Paradigms in Predicting CVD Risk

New Paradigms in Predicting CVD Risk New Paradigms in Predicting CVD Risk Imaging as an Integrator of Lifetime Risk Exposure Michael J. Blaha MD MPH Presented by: Michael J. Blaha September 24, 2014 1 Talk Outline Risk factors vs. Disease

More information

Saturated fat- how long can you go/how low should you go?

Saturated fat- how long can you go/how low should you go? Saturated fat- how long can you go/how low should you go? Peter Clifton Baker IDI Heart and Diabetes Institute Page 1: Baker IDI Page 2: Baker IDI Page 3: Baker IDI FIGURE 1. Predicted changes ({Delta})

More information

Disclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Disclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 2014 AAHP Fall Seminar Sherry Myatt, PharmD, BCPS Assistant Director of Pharmacy for

More information

No relevant financial relationships

No relevant financial relationships MANAGEMENT OF LIPID DISORDERS: WHERE DO WE STAND WITH THE NEW PRACTICE GUIDELINES? Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant financial relationships

More information

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment

More information

Dietary Reference Values: a Tool for Public Health

Dietary Reference Values: a Tool for Public Health HOGE GEZONDHEISRAAD Dietary Reference Values: a Tool for Public Health CONSEIL SUPERIEUR DE LA SANTE Belgian Dietary Reference Values for Energy and Macronutrients: FATS G. De Backer Brussels, February

More information

Chapter 18. Diet and Health

Chapter 18. Diet and Health Chapter 18 Diet and Health Risk Factors and Chronic Diseases Interrelationships among Chronic Diseases Chronic Disease Heart Disease and Stroke Hypertension Cancer Diabetes The Formation of Plaques in

More information

Lipids. PBHL 211 Darine Hachem, MS, LD

Lipids. PBHL 211 Darine Hachem, MS, LD Lipids PBHL 211 Darine Hachem, MS, LD Outline Functions of lipids in our body Types of lipids Sources of lipids Recommendation of fat intake Fat association with heart diseases Provide energy (9Kcal/g

More information

Heart Disease Genesis

Heart Disease Genesis Heart Disease Genesis The Ultimate Lecture on CAD origins Petr Polasek MD FRCPC FACC Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

Diet and Non-Communicable Diseases (NCDs): latest evidence

Diet and Non-Communicable Diseases (NCDs): latest evidence Diet and Non-Communicable Diseases (NCDs): latest evidence Fumiaki Imamura, MS, PhD fumiaki.imamura@mrc-epid.cam.ac.uk 23 Nov 2016, London publications in our field N journals=436 N publications: 90000

More information

Prevention of Heart Disease: The New Guidelines

Prevention of Heart Disease: The New Guidelines Prevention of Heart Disease: The New Guidelines Nisha I. Parikh MD MPH Assistant Professor of Medicine Division of Cardiology Department of Medicine University of California San Francisco May 18 th 2015

More information

Imaging-Guided Statin Allocation: Seeing Is Believing

Imaging-Guided Statin Allocation: Seeing Is Believing Imaging-Guided Statin Allocation: Seeing Is Believing The New Paradigm in Personalized Risk Assessment & Medication Prescribing Presented by: Michael J. Blaha May 15, 2014 1 General Principles of Talk

More information

Short and Long Term Prognosis after Coronary Artery Calcium Scoring

Short and Long Term Prognosis after Coronary Artery Calcium Scoring Short and Long Term Prognosis after Coronary Artery Calcium Scoring In Pre-Elderly and Elderly Patients Michael J. Blaha MD MPH Presented by: Michael J. Blaha July 24, 2017 1 Talk Outline 1. Coronary artery

More information

3/25/2013. Healthy Aging: Approaches to Reduce Chronic Disease Risk. Overview. Chronic disease risk and older adults

3/25/2013. Healthy Aging: Approaches to Reduce Chronic Disease Risk. Overview. Chronic disease risk and older adults Healthy Aging: Approaches to Reduce Chronic Disease Risk Alice H. Lichtenstein, D.Sc. Gershoff Professor of Nutrition Science and Policy Tufts University Overview Chronic disease risk and older adults

More information

Cardiovascular risk potential of dietary saturated fats: an update and some implications

Cardiovascular risk potential of dietary saturated fats: an update and some implications Cardiovascular risk potential of dietary saturated fats: an update and some implications Gerard Hornstra, PhD Med" Prof. Em. of Experimental Nutrition" Maastricht University" The Netherlands" Cardiovascular

More information

Disclosures. Prevention of Heart Disease: The New Guidelines. Summary of Talk. Four guidelines. No relevant disclosures.

Disclosures. Prevention of Heart Disease: The New Guidelines. Summary of Talk. Four guidelines. No relevant disclosures. Disclosures Prevention of Heart Disease: The New Guidelines No relevant disclosures Nisha I. Parikh MD MPH Assistant Professor of Medicine Division of Cardiology Department of Medicine University of California

More information

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??

More information

WHICH DIET FOR THE PREVENTION OF CARDIOVASCULAR DISEASE MEAT OR VEGETARISM

WHICH DIET FOR THE PREVENTION OF CARDIOVASCULAR DISEASE MEAT OR VEGETARISM WHICH DIET FOR THE PREVENTION OF CARDIOVASCULAR DISEASE MEAT OR VEGETARISM QUELLE ALIMENTATION POUR PRÉVENIR LES MALADIES CARDIOVASCULAIRES VIANDE OU VÉGÉTARISME Dr Jean-Michel LECERF Service de Nutrition

More information

Can foods change your health? Good fats and bad fats: what is the evidence? Kay-Tee Khaw. Main categories of fats

Can foods change your health? Good fats and bad fats: what is the evidence? Kay-Tee Khaw. Main categories of fats Can foods change your health? Good fats and bad fats: what is the evidence? Kay-Tee Khaw UNIVERSITY OF CAMBRIDGE Hong Kong July 6 213 Yerushalmy J Hilleboe HE NY State J Med 1957 Coronary heart disease

More information

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t? Primary Prevention of Heart Disease: What works? What doesn t? Samia Mora, MD, MHS Associate Professor, Harvard Medical School Associate Physician, Brigham and Women s Hospital October 2, 2015 Financial

More information

Dairy matrix effects on T2 diabetes and cardiometabolic health?

Dairy matrix effects on T2 diabetes and cardiometabolic health? Department of Nutrition, Exercise and Sports Dairy matrix effects on T2 diabetes and cardiometabolic health? Arne Astrup Head of department, professor, MD, DMSc. Department of Nutrition, Exercise and Sports

More information

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.

More information

CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong

CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong Promises, Pitfalls and Hard Truths of Coronary Calcium Scanning Selwyn Wong Ascot and Middlemore Hospitals Coronary Calcium Scoring

More information

Controversies in Preventative Cardiology

Controversies in Preventative Cardiology Controversies in Preventative Cardiology Francisco Lopez-Jimenez, M.D., M.Sc, FACC, FAHA Professor of Medicine, Mayo Medical School Chair, Division of Preventive Cardiology Co-Director, Artificial Intelligence

More information

Young high risk patients the role of statins Dr. Mohamed Jeilan

Young high risk patients the role of statins Dr. Mohamed Jeilan Young high risk patients the role of statins Dr. Mohamed Jeilan KCS Congress: Impact through collaboration CONTACT: Tel. +254 735 833 803 Email: kcardiacs@gmail.com Web: www.kenyacardiacs.org Disclosures

More information

Sanger Heart & Vascular Institute Symposium 2015

Sanger Heart & Vascular Institute Symposium 2015 Sanger Heart & Vascular Institute Symposium 2015 Cardiovascular Update For Primary Care Physicians William E. Downey, MD FACC FSCAI Medical Director, Interventional Cardiology Sanger Heart & Vascular Institute

More information

The Art of Cardiovascular Risk Assessment

The Art of Cardiovascular Risk Assessment The Art of Cardiovascular Risk Assessment Laurence S. Sperling, M.D., FACC, FACP,FAHA, FASPC Professor of Medicine (Cardiology) Professor of Global Health Director- Center for Heart Disease Prevention

More information

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation 50 YO man NSTEMI treated with PCI 1 month ago Medical History: Obesity: BMI 32,

More information

Nutrition and Heart Disease. by Rachel Kay, MS, RDN, CD Clinical Nutrition Specialist at Swedish Medical Center

Nutrition and Heart Disease. by Rachel Kay, MS, RDN, CD Clinical Nutrition Specialist at Swedish Medical Center Nutrition and Heart Disease by Rachel Kay, MS, RDN, CD Clinical Nutrition Specialist at Swedish Medical Center Objectives 1. Be able to identify recommended diet changes for patients with cardiovascular

More information

Nutrition Counselling

Nutrition Counselling Nutrition Counselling Frieda Dähler Augustiny, Nutritional Counsellor Preventive Cardiology & Sports Medicine University Clinic of Cardiology Optimal Diet for Prevention of Coronary Heart Disease Diet

More information

Fatty acids and cardiovascular health: current evidence and next steps

Fatty acids and cardiovascular health: current evidence and next steps Fatty acids and cardiovascular health: current evidence and next steps Emanuele Di Angelantonio, MD, PhD Department of Public Health and Primary Care NICE guidelines on fatty acids Eliminate the use of

More information

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension. 2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature

More information

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Widespread concern about the role of SFA in heart disease: Is it justified?

Widespread concern about the role of SFA in heart disease: Is it justified? Widespread concern about the role of SFA in heart disease: Is it justified? 1. What is the association of SFA intake and LDL-C? 2. Is LDL-C the best biomarker? 3. If SFA is reduced, does it matter what

More information

Of Cows and Men: Reviewing the Link Between Dairy Fat and Human Health

Of Cows and Men: Reviewing the Link Between Dairy Fat and Human Health Of Cows and Men: Reviewing the Link Between Dairy Fat and Human Health The Times, They Are A Changing To keep in mind: what 100% of experts believe and recommend usually changes over time Thomas Kuhn Eduardo

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

NUTRITION IN THE AGE OF EVIDENCE D A N A H. M A N N I N G P H A R M. D., R. D., L D N

NUTRITION IN THE AGE OF EVIDENCE D A N A H. M A N N I N G P H A R M. D., R. D., L D N NUTRITION IN THE AGE OF EVIDENCE D A N A H. M A N N I N G P H A R M. D., R. D., L D N OBJECTIVES List controversial points from the current Dietary Guidelines for Americans (DGA). Recognize the policy

More information

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society

More information

Diabetes and Heart Disease

Diabetes and Heart Disease Diabetes and Heart Disease Sarah Alexander, MD Assistant Professor of Medicine Division of Cardiology Rush University Medical Center 2/8/2017 Rush is a not-for-profit health care, education and research

More information

LDL and the Benefits of Statin Therapy

LDL and the Benefits of Statin Therapy LDL and the Benefits of Statin Therapy Allan Sniderman McGill University ACC/AHA did not recommend a target-based approach. Right? P 2899 The Expert Panel was unable to find any RCTs that evaluated titration

More information

The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences

The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences What should we be promoting? Define health benefits in terms

More information

Atherosclerotic Disease Risk Score

Atherosclerotic Disease Risk Score Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,

More information

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy

More information

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017 Coronary Artery Calcification Dharmendra A. Patel, MD MPH Director, Echocardiography Laboratory Associate Program Director Cardiovascular Disease Fellowship Program Erlanger Heart and Lung Institute UT

More information

LDL cholesterol and cardiovascular outcomes?

LDL cholesterol and cardiovascular outcomes? LDL cholesterol and cardiovascular outcomes? Prof Kausik Ray, BSc (hons), MBChB, FRCP, MD, MPhil (Cantab), FACC, FESC Professor of Cardiovascular Disease Prevention St Georges University of London Honorary

More information

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING THE DECREASE

More information

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for + Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics

More information

The Mediterranean Diet: The Optimal Diet for Cardiovascular Health

The Mediterranean Diet: The Optimal Diet for Cardiovascular Health The Mediterranean Diet: The Optimal Diet for Cardiovascular Health Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health Cardiovascular Disease Prevention International

More information

ACC/AHA Guidelines Bulls-eyes and Misses

ACC/AHA Guidelines Bulls-eyes and Misses ACC/AHA Guidelines Bulls-eyes and Misses James Trippi, MD, FACC Diplomate American Board of Clinical Lipidology Complex Cholesterol Center of St. Vincent Health Indianapolis, IN October 18, 2014 Level

More information

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials PREVENTING CARDIOVASCULAR DISEASE IN WOMEN: Current Guidelines for Hypertension, Lipids and Aspirin Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial

More information

Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice

Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice Vera Bittner, MD, MSPH Professor of Medicine Section Head, Preventive Cardiology Medical Director, Cardiac Rehabilitation

More information

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD Current Cholesterol Guidelines and Treatment of Residual Risk J. Peter Oettgen, MD Associate Professor of Medicine Harvard Medical School Director, Preventive Cardiology Beth Israel Deaconess Medical Center

More information

Session 21: Heart Health

Session 21: Heart Health Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk

More information

Overview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures

Overview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures The Mediterranean Diet: The Optimal Diet for Cardiovascular Health No conflicts of interest or disclosures Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health

More information

What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline?

What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline? What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline? Salim S. Virani, MD, PhD, FACC, FAHA Associate Professor, Section of Cardiovascular Research Baylor

More information

Disclosures No relationships (not even to an employer) No off-label uses. Cholesterol Lowering Guidelines: What now?

Disclosures No relationships (not even to an employer) No off-label uses. Cholesterol Lowering Guidelines: What now? Disclosures No relationships (not even to an employer) No off-label uses Cholesterol Lowering Guidelines: What now?, FACP 1 2 65-year-old white woman Total cholesterol 175mg/dL HDL 54 mg/dl LDL 96 mg/dl

More information

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Matthew Budoff, MD, FACC, FAHA Professor of Medicine Director, Cardiac CT Harbor-UCLA Medical Center, Torrance, CA

More information

The Clinical Unmet need in the patient with Diabetes and ACS

The Clinical Unmet need in the patient with Diabetes and ACS The Clinical Unmet need in the patient with Diabetes and ACS Professor Kausik Ray (UK) BSc(hons), MBChB, MD, MPhil, FRCP (lon), FRCP (ed), FACC, FESC, FAHA Diabetes is a global public health challenge

More information

Evidence-based priority setting for dietary policies. Ashkan Afshin, MD MPH MSc ScD November 17, 2016 Acting Assistant Professor of Global Health

Evidence-based priority setting for dietary policies. Ashkan Afshin, MD MPH MSc ScD November 17, 2016 Acting Assistant Professor of Global Health Evidence-based priority setting for dietary policies Ashkan Afshin, MD MPH MSc ScD November 17, 2016 Acting Assistant Professor of Global Health 1. Defining optimal nutrition Agenda Setting Policy Formulation

More information

EPOA. Latest Insights on Palm Oil & Health. European Industry Meeting on Palm Oil Nicolette Drieduite I EPOA Project team member I Cargill 2 June 2015

EPOA. Latest Insights on Palm Oil & Health. European Industry Meeting on Palm Oil Nicolette Drieduite I EPOA Project team member I Cargill 2 June 2015 EPOA Latest Insights on Palm Oil & Health European Industry Meeting on Palm Oil Nicolette Drieduite I EPOA Project team member I Cargill 2 June 2015 Summary 1. In the nineties palm oil s success was related

More information

2013 Lipid Guidelines Practical Approach. Edward Goldenberg, MD FACC,FACP, FNLA Medical Director of Cardiovascular Prevention CCHS

2013 Lipid Guidelines Practical Approach. Edward Goldenberg, MD FACC,FACP, FNLA Medical Director of Cardiovascular Prevention CCHS 2013 Lipid Guidelines Practical Approach Edward Goldenberg, MD FACC,FACP, FNLA Medical Director of Cardiovascular Prevention CCHS EVIDENCE BASED MEDICINE Case #1 - LB 42 yo Asian/American female who was

More information

Case Study #4: Hypertension and Cardiovascular Disease

Case Study #4: Hypertension and Cardiovascular Disease Helen Jang Tara Hooley John K Rhee Case Study #4: Hypertension and Cardiovascular Disease 7. What risk factors does Mrs. Sanders currently have? The risk factors that Mrs. Sanders has are high blood pressure

More information

FoodGate: The break-in, cover-up, and aftermath. Robert H. Lustig, M.D., M.S.L. Cristin Kearns, D.D.S., M.B.A. Laura Schmidt, Ph.D., M.P.H., L.C.S.W.

FoodGate: The break-in, cover-up, and aftermath. Robert H. Lustig, M.D., M.S.L. Cristin Kearns, D.D.S., M.B.A. Laura Schmidt, Ph.D., M.P.H., L.C.S.W. FoodGate: The break-in, cover-up, and aftermath Robert H. Lustig, M.D., M.S.L. Cristin Kearns, D.D.S., M.B.A. Laura Schmidt, Ph.D., M.P.H., L.C.S.W. Osher Mini Med School for the Public, Mar 6, 2018 Decrease

More information

CLINICAL OUTCOME Vs SURROGATE MARKER

CLINICAL OUTCOME Vs SURROGATE MARKER CLINICAL OUTCOME Vs SURROGATE MARKER Statin Real Experience Dr. Mostafa Sherif Senior Medical Manager Pfizer Egypt & Sudan Objective Difference between Clinical outcome and surrogate marker Proper Clinical

More information

No conflicts of interest or disclosures

No conflicts of interest or disclosures Egg and Dairy Consumption: Impact on CVD Risk No conflicts of interest or disclosures Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health Cardiovascular Disease

More information

Controlling Cholesterol and Diet Modifications

Controlling Cholesterol and Diet Modifications Reducing your Risk of Heart Disease Webinar Series Controlling Cholesterol and Diet Modifications Created with an educational grant from: About Mended Hearts Mended Hearts mission is: To inspire hope and

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

New ACC/AHA Guidelines on Lipids: Are PCSK9 Inhibitors Poised for a Breakthrough?

New ACC/AHA Guidelines on Lipids: Are PCSK9 Inhibitors Poised for a Breakthrough? New ACC/AHA Guidelines on Lipids: Are PCSK9 Inhibitors Poised for a Breakthrough? Sidney C. Smith, Jr. MD, FACC, FAHA Professor of Medicine/Cardiology University of North Carolina at Chapel Hill Immediate

More information

Global Burden of Disease Attributable to Sugar Sweetened Beverages

Global Burden of Disease Attributable to Sugar Sweetened Beverages Global Burden of Disease Attributable to Sugar Sweetened Beverages Dariush Mozaffarian, MD DrPH Dean, Friedman School of Nutrition Science & Policy Press Conference Mexico City, Mexico November 11, 2014

More information

Questions 4/8/2016. Cholesterol overview. Cholesterol biological functions Component of biological membranes. Cholesterol chemistry

Questions 4/8/2016. Cholesterol overview. Cholesterol biological functions Component of biological membranes. Cholesterol chemistry How much cholesterol can be part of a healthful diet? Dietary cholesterol: The good, the bad, and the egg? Are there specific foods that should be limited because of their cholesterol content? Sonia Vega-López,

More information

Role of Dietary Fats and Cardiovascular Risk

Role of Dietary Fats and Cardiovascular Risk Role of Dietary Fats and Cardiovascular Risk Julie Lovegrove Hugh Sinclair Unit of Human Nutrition & Institute for Cardiovascular and Metabolic Research University of Reading, UK Alpro Student Symposium

More information

1/14/2013 Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of h

1/14/2013 Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of h Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of hyperlipidemia. Identify risk factors that lead to the development

More information

Treating Lipids for Prevention of CAD in Women: Matching Therapy to Risk

Treating Lipids for Prevention of CAD in Women: Matching Therapy to Risk TREATING LIPIDS FOR PREVENTION OF CAD IN WOMEN: MATCHING THERAPY TO RISK Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pokharel Y, Tang F, Jones PG, et al. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in cardiology practices

More information

Case Presentation. Moderator: Sharon Liu, DO Associate Internal Medicine Chief Austin Regional Clinic Austin, Texas

Case Presentation. Moderator: Sharon Liu, DO Associate Internal Medicine Chief Austin Regional Clinic Austin, Texas Case Presentation Moderator: Sharon Liu, DO Associate Internal Medicine Chief Austin Regional Clinic Austin, Texas Izzy (2006) 51 y/o Hispanic woman with a history of diabetes and obesity. Her diabetes

More information

2013 ACC AHA LIPID GUIDELINE JAY S. FONTE, MD

2013 ACC AHA LIPID GUIDELINE JAY S. FONTE, MD 2013 ACC AHA LIPID GUIDELINE JAY S. FONTE, MD How do you interpret my blood test results? What are our targets for these tests? Before the ACC/AHA Lipid Guidelines A1c:

More information

Dietary Cholesterol in Cold Water Prawns: Implications for Cardiovascular Disease Risk

Dietary Cholesterol in Cold Water Prawns: Implications for Cardiovascular Disease Risk Dietary Cholesterol in Cold Water Prawns: Implications for Cardiovascular Disease Risk Professor Bruce Griffin Department of Nutritional Sciences Faculty of Health & Medical Sciences Coronary Heart Disease

More information

Supplemental table 1. Dietary sources of protein among 2441 men from the Kuopio Ischaemic Heart Disease Risk Factor Study MEAT DAIRY OTHER ANIMAL

Supplemental table 1. Dietary sources of protein among 2441 men from the Kuopio Ischaemic Heart Disease Risk Factor Study MEAT DAIRY OTHER ANIMAL ONLINE DATA SUPPLEMENT 1 SUPPLEMENTAL MATERIAL Pork Bacon Turkey Kidney Cream Cottage cheese Mutton and lamb Game (elk, reindeer) Supplemental table 1. Dietary sources of protein among 2441 men from the

More information

Sugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA

Sugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular Health Christina M. Shay, PhD, MA 1 Presenter Disclosure Information Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular

More information

Saturated Fats: What is the Link to Cardiovascular Disease?

Saturated Fats: What is the Link to Cardiovascular Disease? Saturated Fats: What is the Link to Cardiovascular Disease? Benoît Lamarche, PhD Chair of Nutrition School of Nutrition INAF, Université Laval Québec, Canada CNS 2015 Winnipeg Disclosures Funding (last

More information

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

Placebo-Controlled Statin Trials Prevention Of CVD in Women MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

HEART HEALTH AND HEALTHY EATING HABITS

HEART HEALTH AND HEALTHY EATING HABITS HEART HEALTH AND HEALTHY EATING HABITS ELIZABETH PASH PENNIMAN RD,LD CLINICAL DIETITIAN Professional Member American Heart Association; Council on Nutrition, Physical Activity and Metabolism PURPOSE: Recognize

More information

1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver)

1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) I. TEST YOUR KNOWLEDGE OF CHOLESTEROL Choose the correct answer. 1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) 2. Only

More information

UNIVERSITY OF CAMBRIDGE. Fatty acids and heart disease. Kay-Tee Khaw

UNIVERSITY OF CAMBRIDGE. Fatty acids and heart disease. Kay-Tee Khaw UNIVERSITY OF CAMBRIDGE Fatty acids and heart disease Kay-Tee Khaw Bristol 3 October 2013 Yerushalmy J Hilleboe HE NY State J Med 1957 Coronary heart disease death rates in relation to blood cholesterol

More information

Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School

Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review

More information

Giving Good Dietary Advice to Cardiovascular Patients

Giving Good Dietary Advice to Cardiovascular Patients Giving Good Dietary Advice to Cardiovascular Patients Carmine D Amico, D.O. Learning objectives Introduction Basic principles Grocery shopping Cooking Eating out Snacking Staying active Summary Overview

More information

Update on Cholesterol Management: The 2013 ACC/AHA Guidelines

Update on Cholesterol Management: The 2013 ACC/AHA Guidelines Update on Cholesterol Management: The 2013 ACC/AHA Guidelines Ola Akinboboye MD MPH MBA Medical Director, Queens Heart institute Rosedale. Associate Professor of Clinical Medicine, Weill Medical College

More information

NEW CLINICAL GUIDELINES FOR THE MANAGEMENT OF OBESITY AND METABOLIC SYNDROME

NEW CLINICAL GUIDELINES FOR THE MANAGEMENT OF OBESITY AND METABOLIC SYNDROME NEW CLINICAL GUIDELINES FOR THE MANAGEMENT OF OBESITY AND METABOLIC SYNDROME Alexander Frame, Richard Mathias School of Population and Public Health Obesity Pandemic (WHO) Developed Nations Developing

More information